Monday, February 4, 2013- Top Mutual Funds Still Nibbling At Ocwen Financialat Investor's Business Daily (Mon, Feb 4)
- Analyst downgrades Merck on concerns over 2 drugsAP (Mon, Feb 4)
- Merck's Discount Comes At A Priceat Seeking Alpha (Mon, Feb 4)
- Can Big Pharma Bring Big Gains to Your Portfolio?at Motley Fool (Mon, Feb 4)
- Zoetis Commences TradingZacks (Mon, Feb 4)
- Pfizer's 2013 Potential Growth Catalystsat Seeking Alpha (Mon, Feb 4)
- White & Case, Schulte Roth, Skadden, S&C: Business of Lawat Bloomberg (Mon, Feb 4)
- AstraZeneca Forecasts Lower Profit Amid Generic Pressureat Bloomberg (Mon, Feb 4)
- Imminent Catalysts Should Keep Investor Interest Alive For These Pharmaceuticals - Part IIat Seeking Alpha (Mon, Feb 4)
- Aveo Pharma Readies Survival Update For Kidney Cancer Drugat TheStreet (Mon, Feb 4)
Sunday, February 3, 2013 Saturday, February 2, 2013 Friday, February 1, 2013- Pfizer, Bristol-Myers, Johnson And Johnson: Do They Have The Next Plavix, Or Vioxx?at Seeking Alpha (Fri, Feb 1)
- 50 Jaw-Dropping Pharmaceutical, Biotech, and Life Science Statisticsat Motley Fool (Fri, Feb 1)
- These 4 Stocks Help the Dow Reach 14,000at Wall St. Cheat Sheet (Fri, Feb 1)
- Animal Health Firm Zoetis Is Biggest IPO Since Facebookat Motley Fool (Fri, Feb 1)
- Pfizer's animal health unit, Zoetis, soars in IPOAP (Fri, Feb 1)
- News Summary: Pfizer animal health unit IPO soarsAP (Fri, Feb 1)
- Correction: Pfizer-Antidepressant Suit storyAP (Fri, Feb 1)
- Medical Industry Must Disclose Doctor Payments, U.S. Saysat Bloomberg (Fri, Feb 1)
- CEO Says Zoetis to Grow Along With Meat Consumptionat Bloomberg (Fri, Feb 1)
- Merck’s Sales Tumble and Pfizer’s Zoetis Goes Public: Healthcare Recapat Wall St. Cheat Sheet (Fri, Feb 1)
Add PFE News to My Yahoo!   | |
|
0.19(0.65%) May 23, 4:00PM EDT|After Hours
:
29.14